Limp reception for female 'libido drug'
By Clare Wilson More: Read a longer version of this article A DRUG that boosts women’s libido may have come a step closer after apparently positive trials. Dubbed the “female Viagra”, such drugs are objects of desire for the pharmaceutical industry, which sees them as a potential gold mine. However, flibanserin’s effects are modest, and the results have reignited the debate over whether “hypoactive sexual desire disorder”, which the drug claims to treat, is a real medical condition or a variation of normal human behaviour. HSDD, defined as the persistent and distressing lack of sexual desire,